Tag: RET NSCLC

Pulmonary MRI with ultrashort echo time is comparable to pulmonary CT

Selpercatinib vs Chemotherapy and Pembrolizumab in RET Positive NSCLC

byDaniel Goldshteinand1 others

November 7, 2023

1. The progression-free survival was 24.8 months in the selpercatinib group vs 11.2 months in the control group (chemotherapy ± ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen
Nucleoside-modified mRNA influenza vaccine more effective than standard shot in adults
Palliative care involvement and intensity of end-of-life care among adolescents and young adults with cancer: a population-based study

No Result

View All Result